阿奇霉素对支气管哮喘患者肺功能及血清结缔组织生长因子的影响

目的：观察阿奇霉素治疗支气管哮喘的临床疗效,及其对肺功能、血清结缔组织生长因子（Connective tissue growth factor,CTGF）的影响。方法：48例哮喘患者随机分入常规治疗组（A组）,阿奇霉素治疗组（B组）;两组均吸入布地奈德,B组加服阿奇霉素,18名健康体检者做对照组（C组）;ELISA法检测受试者血清中CTGF水平。评估治疗前后,各组患者哮喘控制测试评分、肺功能、血清CTGF的变化。结果：治疗8周后,A、B两组患者的哮喘控制测试评分、肺功能指标均较治疗前有明显改善,血清中CTGF浓度亦明显下降,差异有统计学意义（P均〈0.05）;治疗8周后,B组哮喘控制测试评分、肺功能指标均明显高于A组,但血清CTGF浓度明显低于A组,差异有统计学意义（P均〈0.05）。结论：阿奇霉素可能通过抑制CTGF的表达,抑制气道重塑,改善肺功能,控制哮喘。

Effects of azithromycin on lung function and serum CTGF of asthma patients

AIM. To observe the clinical effi- cacy of azithromycin on bronchial asthma, and the effects on lung function, serum connective tissue growth factor （CTGF）. METHODS： 48 cases of asthma were randomly divided into con- ventional treatment group （group A）, azithro- mycin in treatment group （group B）. Two groups were inhaled budesonide, group B was given azithromycin additional, 18 healthy people were distributed to control group （group C）. The level of serum CTGF was detected by en- zyme-linked immunosorbent assay （ELISA）. The changes of asthma control test （ACT） scores,lung function, serum CTGF were evalua- ted in each group patients before and after treat- ment. RESULTS： After 8 weeks treatment, the levels of ACT scores, lung function were significantly improved than before treatment, but the serum CTGF concentrations were decreased in group A and B （all P 〈 0.05）. After 8 weeks treatment,compared with group A, the levels of ACT scores,lung function were significantly in- creased in group B, but the CTGF serum con- centration was decreased （all P 〈 0.05）. CON- CLUSlON. Azithromycin can inhibit airway re- modeling, improve lung function and control asthma, the reason may be related to inhibiting the expression of CTGF.